Physician profile
Jami Maddox
NPI 1306826524
$1,037.66
in general payments reported to CMS, 2019-2025
16 companies · $324 in 2025
The $324 reported for 2025 was more than what 90% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $149 · 2022: $139 · 2023: $328 · 2024: $97.96 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $271.73 | 2021-2025 | Wegovy, Saxenda |
| Abbvie INC. | $197.28 | 2021-2024 | |
| Biogen, INC. | $110.41 | 2025 | Zurzuvae |
| Teleflex LLC | $86.06 | 2025 | Barrigel, Urolift |
| Daiichi Sankyo INC. | $71.34 | 2022-2023 | Injectafer |
| Pfizer INC. | $49.08 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $35.75 | 2021-2023 | |
| Pacira Pharmaceuticals Incorporated | $33.29 | 2023 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $30.62 | 2023 | Trintellix |
| Boston Scientific Corporation | $29.49 | 2025 | Spaceoar Vue System - 10ml |
| Axonics, INC. | $28.74 | 2023-2024 | Axonics, Bulkamid |
| Lilly USA, LLC | $23.05 | 2025 | Zepbound, Mounjaro |
| Janssen Biotech, INC. | $21.49 | 2025 | Erleada |
| Merck Sharp & Dohme LLC | $20.21 | 2023 | Gardasil 9 |
| Sumitomo Pharma America, INC. | $15.01 | 2023 | Gemtesa |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $14.11 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jami Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.